Naka Nutri Cure V3 Curcumen 30 Veg caps

Description The longvida® difference: SLCP™ technology Patented solid lipid curcumin particle (SLCP™) technology enables the uptake of free form (native or intact) curcumin through the lymphatic system by delivering to target tissues via chylomicrons. Extensively studied by independent researchers globally, longvida® optimized curcumin is able to cross the blood-brain barrier, offering efficacious amounts of free form curcumin at easily managed daily doses. Bioavailability more than a dozen clinical findings show that longvida® optimized curcumin delivers free form curcumin to target tissues. Studied extensively by independent academic and medical centers globally, longvida® is 67-285 times more bioavailable than standard 95% Curcumin depending on CMAX, AUC, and AUC normalized calculations. Additionally, longvida® offers a longer half-life than standard curcumin. Longvida® bioavailability – absorption is just the beginning AUC(0-t) value: 95.26 (95.26/ND × 650/650 ) (AUC of test(curcumin in longvida®) dose of ref (95% curcuminoid) References Gota, V. S., Maru, G. B., Soni, T. G., Gandhi, T. R., Kochar, N., & Agarwal, M. (2010). Safety and pharmacokinetics of a solid lipid curcumin particle Formulation in osteosarcoma patients and healthy volunteers. Journal of Agricultural and food chemistry, 58(4), 2095-2099. Longvida® extract is patented under us 9192644 & ep 1993365 (other Patents pending) and longvida® is a registered trademark of verdure Sciences inc.